With the analysis among 2,220 patents, we discovered top 392 key players by total patent application. Novartis AG, Janssen Pharmaceutica NV, GlaxoSmithKline LLC are dominant in this area. They take 12.21% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 105
Antwerpen, Belgium
Patent: 91
Pennsylvania, United States
Patent: 75
New York, United States
Patent: 74
Esperion Therapeutics, Inc.
Michigan, United States
Patent: 72
Fujisawa Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 55
Hovedstaden, Denmark
Patent: 54
Pennsylvania, United States
Patent: 47
Tokyo-to, Japan
Patent: 40
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 39
With the analysis among 71 patents, we discovered top 11 start-ups by total patent application. Espervita Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Dermavant Sciences GmbH are active in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Institut National de la Santé et de la Recherche Médicale
Basel-Stadt, Switzerland
Patent: 10
SciCann Therapeutics, Inc.
California, United States
Patent: 4
Emerald Health Pharmaceuticals, Inc.
California, United States
Patent: 3
Shenzhen Evergreen Therapeutics Co., Ltd.
Guangdong Sheng, China
Patent: 3
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 3
New York, United States
Patent: 2
Basel-Stadt, Switzerland
Patent: 1
With the analysis among related 537 patents applied in the last 5 years. We discover 184 most active companies in this area. The fast-growing Espervita Therapeutics, Inc., West China Hospital of Sichuan University, Melior Discovery, Inc. take 9.50% of patent filing during this period.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
West China Hospital of Sichuan University
Pennsylvania, United States
Patent: 14
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
Louisiana State University
Louisiana, United States
Patent: 11
Cystic Fibrosis Foundation
Boehringer Ingelheim Animal Health USA, Inc.
Georgia, United States
Patent: 9
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Uttar Pradesh, India
Patent: 9
With the analysis among related 537 patents in last 5 years, we discover 133 new entrants. Espervita Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Louisiana State University are the most active new entrants in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
Louisiana State University
Louisiana, United States
Patent: 11
Uttar Pradesh, India
Patent: 9
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 8
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 8
SciCann Therapeutics, Inc.
The University of Liverpool
CITY OF LIVERPOOL, United Kingdom
Patent: 6
First Affiliated Hospital of Dalian Medical University
Liaoning Sheng, China
Patent: 5
Pliant Therapeutics, Inc.
California, United States
Patent: 5
With the analysis among 585 patents, we discovered top 79 universities and scientific research institutions by total patent application. Katholieke Universiteit Leuven, President & Fellows of Harvard College, Kharkiv National Medical University are dominant in this area. They take 13.68% of the total patent filing.
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 25
President & Fellows of Harvard College
Massachusetts, United States
Patent: 21
Kharkiv National Medical University
Louisiana State University
Louisiana, United States
Patent: 11
The Salk Institute for Biological Studies
California, United States
Patent: 9
Georgia, United States
Patent: 8
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 8
BRISTOL, United Kingdom
Patent: 7
The University of Liverpool
CITY OF LIVERPOOL, United Kingdom
Patent: 6